Medical Membrane Market - Databook 2025 to 2034

The global medical membrane market size accounted for USD 4.22 billion in 2024 and is predicted to touch around USD 8.71 billion by 2034, growing at a CAGR of 7.55% from 2025 to 2034.

Highlights of the Medical Membrane Market

• Europe dominated the global medical membrane market in 2024.
• North America is projected to host the fastest-growing market in the coming years.
• By material, the polysulphone (PSU) & polyether sulphone (PESU) segments dominated the medical membrane market in 2024.
• By material, the polypropylene segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By technology, the nanofiltration segment accounted for a considerable share of the medical membrane market in 2024.
• By technology, the ultrafiltration segment is projected to experience the highest growth rate in the market between 2025 and 2034.
• By application, the pharmaceutical filtration segment led the medical membrane market.
• By application, the IV infusion & sterile filtration segment is set to experience the fastest rate of market growth from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The medical membrane is a thin, pliable layer of tissue that lines a tube, or cavity, covers an organ or structure, or separates one part from another. The benefits of medical membranes include shielding elements to block electrostatic discharge (ESD) without compromising overall performance, design-friendly, lightweight, durable & resistant to elements, improved user experience, sanitization, cleanliness, and graphic visibility. Technological advancements, demographic trends, and healthcare infrastructure are driving the growth of the medical membrane market.

• According to a report published in 2024, among people treated with PD, the proportion who died within the first year on dialysis was between 1% and 10% in 74 countries (58%), 11% and 20% in 18 countries (14%), 21% and 30% in 5 countries (4%).

Medical Membrane: Stats and Figures

• According to a report published by the International Society of Nephrology, there are more than 850 million people who suffer from some form of kidney disease, which is rising every year.
• The prevalence of CKD worldwide is 10.4% among men and 11.8% among women. AKI, experienced by 13.3 million people each year, may resolve or lead to CKD or kidney failure in the future.

How has AI Benefited the Medical Membrane Market?

Artificial intelligence (AI) can improve performance and sustainability in membrane separation processes. Machine learning (ML) models predict rejection rates, permeate flux, and fouling with high accuracy. AI optimization eliminates energy use and fouling in membrane separation processes. The hybrid model enhances the accuracy and interpretability of AI predictions. AI analysis of ophthalmic images and clinical features can improve ERM detection, characterization, and prognostication, potentially enhancing clinical decision making.

Industry Leader Announcements

• Yu Hasegawa, Managing Executive and Senior General Manager of the Electronics Interconnecting Materials Division at Asahi Kasei

Yu Hasegawa, Managing Executive and Senior General Manager of the Electronics Interconnecting Materials Division at Asahi Kasei, said, “The development of the TA Series comes after years of close collaboration with our customers and a deep understanding of their most pressing pain points. Through this development, we address the evolving needs of semiconductor packaging in AI, automotive, and IoT applications.”

• Julie Sawyer Montgomery, Executive Vice President, Danaher Corporation

Julie Sawyer Montgomery, Executive Vice President, Danaher Corporation said, “Patients are at the center of everything we do at Danaher. We believe our investment partnership with Innovaccer will empower patients and speed the transition to more personalized, value-based medicine providing healthcare providers with the data and analytics needed to drive meaningful clinical insights, more quickly and at the point of need.”

Geographical Insights

Europe dominated the global medical membrane market in 2024. Rising awareness and acceptance of amniotic membrane products, innovations in tissue engineering and biotechnology, and rising incidences of chronic wounds are driving the growth of the market in the European region.

North America is projected to host the fastest-growing market in the coming years. Growing demand for regenerative medicine, increasing investment in infrastructure & technology, expanding economies, rising consumer demand, urbanization, and rapid industrialization contributing to the growth of the medical membrane market in the North American region.

Recent Developments in the Medical Membrane Market

• In June 2024, selling a membrane system to produce WFI (Water for injection), a type of sterile water that is used for the preparation of injections, was started by Asahi Kasei. The membrane system was developed as an alternative to the conventional distillation processes for the production of WFI by leveraging the system design and development capabilities of Asahi Kasei’s Microza hollow fiber membrane for water treatment and filtration of liquid products.
• In October 2024, the launch of the Extracorporeal Membrane Oxygenation (ECMO) program, a cutting-edge life support system that offers critically ill patients a vital chance at recovery when conventional treatment fails, was announced by UT Health East Texas.

Competitive Landscape

• Company Name: Asahi Kasei
• Year of Incorporation: 1931
• Headquarters: Chiyoda City, Tokyo, Japan

More than 20 countries where it operates. It operates in the healthcare, homes, and material sectors around the world.

• Company Name: Danaher Corporation
• Year of Incorporation: 1984
• Headquarters: Washington, D.C., United States

In 50 different countries where it operates. It operates in the biotechnology, diagnostics, and life sciences sectors, which helps to improve healthcare around the world.